A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Clinical trial NCT05509777 · RECRUITING

Trial details

NCT number: NCT05509777
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2024-03-13
Primary completion: 2027-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.